Group 1 - Waratah Minerals (ASX: WTM) successfully raised AUD 30 million through a strategic placement at AUD 0.575 per share, aimed at accelerating exploration activities at the Spur gold-copper project [3][4] - The company currently has three drilling rigs on site and expects to release exploration results in the coming weeks and months [3] - Following the announcement, WTM's stock price surged by 21.95% to close at AUD 0.75, with a market capitalization of AUD 175 million [4] Group 2 - Catalyst Metals (ASX: CYL) reported significant high-grade gold intercepts outside the Trident resource body, which has doubled its controlled resource to 795,000 ounces [9][10] - The intercepts include a notable 11-meter section with 7.1 grams per tonne of gold, located over 250 meters from the known resource [10] - CYL's stock price increased by 5.52% to AUD 6.88, with a market capitalization of AUD 1.73 billion [11] Group 3 - Blinklab (ASX: BB1) announced significant progress in its clinical trial for early autism screening in children, with results expected in Q3 2025 [15] - The company’s main research phase has received approval from the U.S. Institutional Review Board (IRB) [15] - BB1's stock price rose by 20.46% to AUD 0.53, with a market capitalization of AUD 46.25 million [15] Group 4 - Audeara (ASX: AUA) entered a five-year licensing agreement with Dongke Group to expand its hearing technology into the Chinese medical device market [18] - The products are expected to launch in the second half of the year and will be sold through major Chinese e-commerce platforms [18] Group 5 - Cochlear Limited (ASX: COH) reported a 4% increase in revenue to AUD 2.356 billion and a 9% rise in statutory net profit to AUD 389 million for FY2025 [20] - The company launched the Cochlear™ Nucleus® Nexa™ system, the world's first smart cochlear implant system with upgradable firmware [20] - COH expects a base net profit of AUD 435 million to AUD 460 million for FY2026, representing a growth of 11% to 17% [20] Group 6 - WAM Leaders Limited (ASX: WLE) announced a significant profit increase and raised its fully franked annual dividend despite underperforming against market benchmarks [22][23] - The company reported a pre-tax profit of AUD 79 million, nearly quadrupling year-on-year, and a final dividend of AUD 9.4 cents per share [28] Group 7 - Baby Bunting Group Limited (ASX: BBN) achieved a 228% increase in adjusted net profit to AUD 12.1 million for FY25, with a record gross margin of 40.2% [31][32] - The company plans to complete 10-12 store renovations and expand by up to 8 new stores in FY26 [33] Group 8 - Tetratherix Limited (ASX: TTX) received AUD 3.3 million in government funding to support its synthetic polymer production facility project [36] - The funding will be used to expand capacity and support the launch of bone regeneration products in the U.S. market in 2026 [36] Group 9 - Dateline Resources Ltd (ASX: DTR) reported significant political support for its Colosseum gold-rare earth project in California, which is seen as crucial for reducing U.S. reliance on Chinese supply chains [38] - DTR's stock price is currently at AUD 0.165, with a market capitalization of AUD 527 million [38] Group 10 - AML3D Ltd (ASX: AL3) completed the commissioning of a large-scale industrial metal 3D printing system for the Tennessee Valley Authority, marking a shift from defense to other industry markets [43] - AL3's stock price rose by 16.07% to AUD 0.325, with a market capitalization of AUD 177 million [43] Group 11 - Avita Medical Inc (ASX: AVH) successfully raised AUD 2.3 million through a private placement to cover operational funding needs before generating free cash flow in 2026 [47] - The company reported a 21.2% year-on-year increase in sales revenue for Q2, amounting to USD 18.23 million [47]